MedTrace Logo

Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women

NCT00301353 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2015-05-21

No results posted yet for this study

Summary

Osteoporosis is a major health problem. It was hypothesized that isoflavone-containing products may be a potential alternative to HRT for preventing bone loss during the menopausal transition. We investigated whether one-year consumption of isoflavone-enriched foods affected bone mineral density, bone metabolism and hormonal status in early postmenopausal women in a randomized double-blind, placebo controlled parallel multi-centre trial.

Conditions

Interventions

DRUG

Isoflavones-enriched foods

Sponsors & Collaborators

  • European Commission

    collaborator OTHER

  • National Institute for Research on Food and Nutrition

    collaborator UNKNOWN

  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

    collaborator OTHER

  • TNO

    lead OTHER

Principal Investigators

  • Elizabeth Brink, PhD · TNO

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-10-31
Completion
2004-07-31

Countries

  • France
  • Italy
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00301353 on ClinicalTrials.gov